| Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake M Beg, N Abdullah, FS Thowfeik, NK Altorki, TE McGraw elife 6, e26896, 2017 | 160 | 2017 |
| Excessive reactive oxygen species and exotic DNA lesions as an exploitable liability SF AbdulSalam, FS Thowfeik, EJ Merino Biochemistry 55 (38), 5341-5352, 2016 | 88 | 2016 |
| Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release KT Hufziger, FS Thowfeik, DJ Charboneau, I Nieto, WG Dougherty, ... Journal of inorganic biochemistry 130, 103-111, 2014 | 61 | 2014 |
| Ruthenium complexes are pH-activated metallo prodrugs (pHAMPs) with light-triggered selective toxicity toward cancer cells F Qu, S Park, K Martinez, JL Gray, FS Thowfeik, JA Lundeen, AE Kuhn, ... Inorganic Chemistry 56 (13), 7519-7532, 2017 | 53 | 2017 |
| Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors E Amato, T Bankemper, R Kidney, T Do, A Onate, FS Thowfeik, EJ Merino, ... Bioorganic & medicinal chemistry 22 (1), 126-134, 2014 | 25 | 2014 |
| Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemia TR Bell-Horwath, AK Vadukoot, FS Thowfeik, G Li, M Wunderlich, ... Bioorganic & medicinal chemistry letters 23 (10), 2951-2954, 2013 | 22 | 2013 |
| A ROS‐Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds FS Thowfeik, SF AbdulSalam, M Wunderlich, M Wyder, KD Greis, ... Chembiochem 16 (17), 2513-2521, 2015 | 9 | 2015 |
| Targeting a common enemy: Toxic cellular mechanism of novel anti-cancer agents that alter DNA and transcription FS Thowfeik University of Cincinnati, 2016 | 7 | 2016 |
| Chiral histone deacetylase inhibitors: Synthesis and biological evaluation A Onate, J Tucker, E Hogle, T Do, F Thowfeik, E Merino, L Ma ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
| Structure-activity relationship study on histone deacetylase (HDAC) inhibitors derived from Santacruzamate E Hogle, A Onate, J Tucker, R Leduc, T Do, R Klein, F Thowfeik, E Merino, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
| Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release E Papish, M Lockart, K Jernigan, D Charboneau, K Hughes, S Brown, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | | 2015 |
